Health / Medical Topics

    IL-2/Lptn Gene-Modified Allogeneic Neuroblastoma Tumor Cell Vaccine

    A cancer vaccine consisting of allogeneic neuroblastoma tumor cells have been genetically modified to secrete the human cytokine interleukin-2 (IL-2) and the human chemokine lymphotactin (Lptn) with potential immunostimulating and antineoplastic activities. Upon administration, IL-2 and Lptn are secreted by the IL-2/Lptn gene-modified allogeneic neuroblastoma tumor cell vaccine, potentially enhancing the cytotoxic T lymphocyte (CTL) response elicited by vaccine neuroblastoma tumor-associated antigens (TAAs) against host neuroblastoma tumor cells. Produced by activated progenitor T cells, Lptn belongs to the C chemokine subfamily and is a potent chemotactic factor for lymphocytes; IL-2 stimulates natural killer (NK) cells and may enhance a vaccine-elicited CTL immune response against tumor cells. (NCI Thesaurus)




    YOU MAY ALSO LIKE

    A recombinant protein consisting of the cytokine interleukin-2 (IL-2) fused to a humanized soluble T-cell receptor (TCR) directed against a tumor suppressor…
    An immunotherapeutic agent consisting of a plasmid DNA encoding human Interleukin-2 (IL-2) complexed with a cationic lipid, 1,2-dimyristyloxypropyl-3-dimethyl-hydroxyethyl ammonium bromide/dioleyl-phosphatidyl-ethanolamine (DMRIE/DOPE), in…
    One of a group of related proteins made by leukocytes (white blood cells) and other cells in the body. IL-2 is made…
    One of a group of related proteins made by leukocytes (white blood cells) and other cells in the body. IL-1B, one form…
    One of a group of related proteins made by leukocytes (white blood cells) and other cells in the body. IL-13 is made…
    One of a group of related proteins made by leukocytes (white blood cells) and other cells in the body. IL-12 is made…

    © 1991-2023 The Titi Tudorancea Bulletin | Titi Tudorancea® is a Registered Trademark | Terms of use and privacy policy
    Contact